AML
News
FDA approves olutasidenib for some AML patients
Olutasidenib has been green-lighted by the FDA for treatment of some patients with acute myeloid leukemia.
Feature
Worldwide trial seeks to revolutionize pediatric leukemia care
Leukemia & Lymphoma Society project offers free genomic screening, plus access to subtrials.
From the Journals
Drug combo holds promise of better AML outcomes
Study suggests that the venetoclax-gilteritinib drug combination “potentially improves response frequency and depth.”
Latest News
`Wonder Woman’ launches myelofibrosis research foundation
Honoring her late husband’s battle with a bone marrow disorder, TV actor Lynda Carter establishes a research foundation.
From the Journals
Pivotal trials in blood cancers don’t mirror patient populations
“The results from this study should lead to questions about the generalizability of drug safety and efficacy in populations we serve as medical...
Bloodlines
Bias and other barriers to HSCT access
A view from the world of cellular therapy and hematopoietic stem cell transplantation.
News
First drug therapy approved for childhood GVHD
FDA greenlights ibrutinib for child blood cancer patients with chronic graft-versus-host disease.
From the Journals
AML’s seasonal peak suggests viral or environmental etiology
“The environmental triggers involved could be radiation, pollution, allergens, or infectious agents like viruses.”
Conference Coverage
Fourth patient cleared of HIV after stem cell transplant for blood cancer
“Although a transplant is not an option for most people with HIV, these cases are still interesting, still inspiring, and help illuminate the...
Conference Coverage
‘Superior’ CLL regimen cuts chemo in half
Where chemo is still used to treat CLL, this three-cycle regimen combined with ibrutinib and obinutuzumab shows progression-free and overall...
Guidelines
Evidence still lacking that vitamins prevent CVD, cancer: USPSTF
In its final recommendation statement on the subject, the task force does, however, recommend against use of vitamin E and beta-carotene.